KQ · Healthcare

Prestige Biologics Co. Ltd. (334970)

Pharmaceuticals

Prestige Biologics Co. Ltd. (334970) is listed on KQ in the Healthcare sector. Industry: Pharmaceuticals. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 334970

P/E ratio

18.00

Prestige Biologics Co. Ltd. (334970) — FAQ

What is 334970's P/E ratio?

The price-to-earnings (P/E) ratio for Prestige Biologics Co. Ltd. (334970) is 18.00 (data as of 2026-05-24).

Does Prestige Biologics Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Prestige Biologics Co. Ltd. (334970). Check the MyAverix Finance app for the latest dividend data.

What sector is Prestige Biologics Co. Ltd. in?

Prestige Biologics Co. Ltd. (334970) is classified in the Healthcare sector (Pharmaceuticals industry).

What exchange is 334970 listed on?

334970 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)